Els Witteveen

Full Professor

Contact

pwitteve@umcutrecht.nl

Pure profile

Recent publications

All publications

Long-term neurocognitive, psychosocial, and physical outcomes after prenatal exposure to radiotherapy Indra A Van Assche, Kristel Van Calsteren, Jurgen Lemiere, Jana Hohmann, Jeroen Blommaert, Evangeline A Huis In 't Veld, Elyce Cardonick, Charlotte LeJeune, Nelleke P B Ottevanger, Els P O Witteveen, Martine van Grotel, Marry M van den Heuvel-Eibrink, Lieven Lagae, Maarten Lambrecht, Frédéric Amant
The Lancet. Child & adolescent health, 2024, vol. 8, p.433-442

Pazec Anneke Westermann, Petronella Ottevanger, An Reyners, Judith R Kroep, Martijn G H Van Oijen, Roy Lalisang, Petronella O Witteveen
International Journal of Gynaecological Cancer, 2024, vol. 34, p.239-243

Hormone Receptor Expression and Activity for Different Tumour Locations in Patients with Advanced and Recurrent Endometrial Carcinoma Maartje M.W. Luijten, Willem Jan van Weelden, Roy I. Lalisang, Johan Bulten, Kristina Lindemann, Heleen J. van Beekhuizen, Hans Trum, Dorry Boll, Henrica M.J. Werner, Luc R.C.W. van Lonkhuijzen, Refika Yigit, Camilla Krakstad, Petronella O. Witteveen, Khadra Galaal, Alexandra A. van Ginkel, Eliana Bignotti, Vit Weinberger, Sanne Sweegers, Ane Gerda Z. Eriksson, Diederick M. Keizer, Anja van de Stolpe, Andrea Romano, Johanna M.A. Pijnenborg
Cancers, 2024, vol. 16

WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer Alaa Embaby, Joachim Kutzera, Jill J Geenen, Dick Pluim, Ingrid Hofland, Joyce Sanders, Marta Lopez-Yurda, Jos H Beijnen, Alwin D R Huitema, Petronella O Witteveen, Neeltje Steeghs, Gijs van Haaften, Marcel A T M van Vugt, Jeroen de Ridder, Frans L Opdam
Gynecologic Oncology, 2023, vol. 174, p.239-246

Frailty and checkpoint inhibitor toxicity in older patients with melanoma Cheryl P. Bruijnen, José J. Koldenhof, Rik J. Verheijden, Frederiek van den Bos, Mariëlle H. Emmelot-Vonk, Petronella O. Witteveen, Karijn P.M. Suijkerbuijk
Cancer, 2022, vol. 128, p.2746-2752

Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial) C C B Post, A M Westermann, I A Boere, P O Witteveen, P B Ottevanger, G S Sonke, R I Lalisang, H Putter, E Meershoek-Klein Kranenbarg, J P B M Braak, C L Creutzberg, T Bosse, J R Kroep
Gynecologic Oncology, 2022, vol. 165, p.223-229

External positions

Working group member Dutch working group on Evidence Based Guidelines in gyn cancers - ja - Dutch Working Group on Evidence Based Guidelines

Voorzitter centrale MIP commissie - - UMCU

Advisory board Priority Program Cancer - - UMCU

Steering Committee Expensive Medicines - - UMCU

Member of working group NFU oncology on behalf of University Medical Center Utrecht, Cancer Center - volledig - NFU